Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation

Completed · Not applicable

Conditions studied: Healthy

In brief

Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and skin pigmentation.

Key facts

Study ID: NCT05083351
Run by: Masimo Corporation
People needed: 88
Starts: 2021-10-13
Expected to finish: 2021-12-17
Last updated by the study team: 2024-09-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subject is 18 to 50 years of age.
Subject weighs a minimum of 110 lbs.
Subject has a hemoglobin value ≥ 11 g/dL.
Subject's baseline heart rate is ≥ 45 bpm and ≤ 85 bpm.
Subject's CO value is ≤ 2.0% FCOHb.
Subject's blood pressure: Systolic BP ≤ 140 mmHg and ≥ 90 mmHg, Diastolic BP ≤ 90 mmHg and ≥ 50 mmHg, and if systolic BP is lower than 100 mmHg and/or diastolic BP is lower than 60 mmHg, subject passes an orthostatic blood pressure test.
Subject is able to read and communicate in English and understands the study and the risks involved.

You may not qualify if…

Subject is pregnant.
Subject has a BMI > 35.
Subject has a history of fainting (vasovagal syncope), blacking out or losing consciousness during or after a blood draw, or has a fear of blood draws.
Subject has open wounds, inflamed tattoos or piercings, and/or has any visible healing wounds that a medical professional determines may place them at an increased risk for participation.*
Subject has known drug or alcohol abuse.
Subject uses recreational drugs.*
Subject experiences frequent or severe headaches and/or migraine headaches, migraine auras, altitude sickness, and/or headaches accompanied by visual changes or sensitivity to light or sound.
Subject has experienced a concussion or head injury with loss of consciousness within the past 12 months.
Subject has any history of a stroke, myocardial infarction (heart attack), and/or seizures.
Subject has any chronic bleeding disorder (e.g. hemophilia).
Subject has taken anticoagulant medication within the past 30 days (excluding nonsteroidal anti-inflammatory drugs (NSAIDS)).
Subject has donated blood within the past 4 weeks.
Subject has Wolff-Parkinson-White Syndrome or Stokes-Adams Syndrome.
Subject has any symptomatic cardiac dysrhythmia (e.g. atrial fibrillation) and has not received clearance from their physician to participate.
Subject has a known neurological and/or psychiatric disorder (e.g. schizophrenia, bipolar disorder, multiple sclerosis, Huntington's disease) that interferes with the subject's level of consciousness.*
Subject has taken opioid pain medication 24 hours before the study.
Subject has any active signs and/or symptoms of infectious disease (e.g. hepatitis, HIV, tuberculosis, flu, malaria, measles, etc.).*
Subject is taking medications known to treat any type of infectious disease.
Subject has either signs or history of peripheral ischemia or carpal tunnel syndrome.
Subject has had invasive surgery within the past year, including but not limited to major dental surgery, appendectomy, plastic surgery, jaw surgery, major ENT surgery, major abdominal and/or pelvic surgery, heart surgery, or thoracic surgery.*
Subject has symptoms of congestion, head cold, or other illnesses.
Subject has been in a severe car accident(s) or a similar type of accident(s) requiring hospitalization within the past 12 months.
Subject has any cancer or history of cancer (not including skin cancer).*
Subject has chronic unresolved asthma, lung disease (including COPD) and/or respiratory disease.
Subject is allergic to lidocaine, chlorhexidine, latex, adhesives, or plastic.

Where it is running

Masimo Corporation — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.